PMC:7299399 / 28936-29171 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T105","span":{"begin":125,"end":133},"obj":"Disease"},{"id":"T106","span":{"begin":226,"end":234},"obj":"Disease"}],"attributes":[{"id":"A105","pred":"mondo_id","subj":"T105","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A106","pred":"mondo_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"According to the first Phase III clinical studies, the antiviral drug Remdesivir, which was recently approved by the FDA for COVID-19 treatment in the United States, seems to be a promising treatment for adults diagnosed with COVID-19."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T275","span":{"begin":178,"end":179},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"According to the first Phase III clinical studies, the antiviral drug Remdesivir, which was recently approved by the FDA for COVID-19 treatment in the United States, seems to be a promising treatment for adults diagnosed with COVID-19."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T216","span":{"begin":55,"end":69},"obj":"Chemical"},{"id":"T217","span":{"begin":55,"end":64},"obj":"Chemical"},{"id":"T218","span":{"begin":65,"end":69},"obj":"Chemical"}],"attributes":[{"id":"A216","pred":"chebi_id","subj":"T216","obj":"http://purl.obolibrary.org/obo/CHEBI_36044"},{"id":"A217","pred":"chebi_id","subj":"T217","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A218","pred":"chebi_id","subj":"T218","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"According to the first Phase III clinical studies, the antiviral drug Remdesivir, which was recently approved by the FDA for COVID-19 treatment in the United States, seems to be a promising treatment for adults diagnosed with COVID-19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T113","span":{"begin":0,"end":235},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"According to the first Phase III clinical studies, the antiviral drug Remdesivir, which was recently approved by the FDA for COVID-19 treatment in the United States, seems to be a promising treatment for adults diagnosed with COVID-19."}

{"project":"LitCovid-PubTator","denotations":[{"id":"442","span":{"begin":70,"end":80},"obj":"Chemical"},{"id":"444","span":{"begin":125,"end":133},"obj":"Disease"},{"id":"445","span":{"begin":226,"end":234},"obj":"Disease"}],"attributes":[{"id":"A442","pred":"tao:has_database_id","subj":"442","obj":"MESH:C000606551"},{"id":"A444","pred":"tao:has_database_id","subj":"444","obj":"MESH:C000657245"},{"id":"A445","pred":"tao:has_database_id","subj":"445","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"According to the first Phase III clinical studies, the antiviral drug Remdesivir, which was recently approved by the FDA for COVID-19 treatment in the United States, seems to be a promising treatment for adults diagnosed with COVID-19."}